Literature DB >> 1653787

Seroreactive recombinant herpes simplex virus type 2-specific glycoprotein G.

D L Parkes1, C M Smith, J M Rose, J Brandis, S R Coates.   

Abstract

The herpes simplex virus type 2 (HSV-2) genome codes for an envelope protein, glycoprotein G (gG), which contains predominantly type 2-specific epitopes. A portion of this gG gene has been expressed as a fusion protein in Escherichia coli. Expression was regulated by a lambda phage pL promoter. The 60,000-molecular-weight recombinant protein was purified by ion-exchange chromatography. Amino acid sequence analysis confirmed the N terminus of the purified protein. Mice immunized with recombinant gG developed antibodies reactive with native HSV-2 protein, but not with HSV-1 protein, in an indirect immunofluorescence assay. The serological activity of this purified recombinant gG protein was evaluated by immunoblot assay. This protein was reactive with an HSV-2 gG monoclonal antibody. It was also reactive with HSV-2 rabbit antiserum but not with HSV-1 rabbit antiserum. Of 15 patient serum samples known to have antibody to HSV-2, 14 were reactive with this recombinant type 2-specific gG protein, and none of 15 HSV antibody-negative patient serum samples showed reactivity. In agreement with the expected prevalence of HSV-2 infection, 27.6% of 134 serum samples from random normal individuals had antibodies reactive with recombinant gG. This recombinant gG protein may be of value in detecting HSV-2-specific antibody responses in patients infected with HSV-2.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1653787      PMCID: PMC269869          DOI: 10.1128/jcm.29.4.778-781.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes.

Authors:  W M Sullender; L L Yasukawa; M Schwartz; L Pereira; P A Hensleigh; C G Prober; A M Arvin
Journal:  J Infect Dis       Date:  1988-01       Impact factor: 5.226

2.  Immunoblotting and enzyme-linked immunosorbent assay analysis of serological responses in patients infected with herpes simplex virus types 1 and 2.

Authors:  M Lehtinen; V Koivisto; T Lehtinen; J Paavonen; P Leinikki
Journal:  Intervirology       Date:  1985       Impact factor: 1.763

3.  Solid phase radioimmunoassay for typing herpes simplex viral antibodies in human sera.

Authors:  B Forghani; N J Schmidt; E H Lennette
Journal:  J Clin Microbiol       Date:  1975-11       Impact factor: 5.948

4.  DNA sequence and genetic content of the HindIII l region in the short unique component of the herpes simplex virus type 2 genome: identification of the gene encoding glycoprotein G, and evolutionary comparisons.

Authors:  D J McGeoch; H W Moss; D McNab; M C Frame
Journal:  J Gen Virol       Date:  1987-01       Impact factor: 3.891

5.  Synthesis and processing of glycoprotein gG of herpes simplex virus type 2.

Authors:  N Balachandran; L M Hutt-Fletcher
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

6.  Detection of herpes simplex virus type 2-specific antibody with glycoprotein G.

Authors:  F K Lee; R M Coleman; L Pereira; P D Bailey; M Tatsuno; A J Nahmias
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

7.  Transmission of genital herpes by donor insemination.

Authors:  D E Moore; R L Ashley; P W Zarutskie; R W Coombs; M R Soules; L Corey
Journal:  JAMA       Date:  1989-06-16       Impact factor: 56.272

8.  A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States.

Authors:  R E Johnson; A J Nahmias; L S Magder; F K Lee; C A Brooks; C B Snowden
Journal:  N Engl J Med       Date:  1989-07-06       Impact factor: 91.245

9.  Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infection.

Authors:  A Langenberg; J Benedetti; J Jenkins; R Ashley; C Winter; L Corey
Journal:  Ann Intern Med       Date:  1989-06-01       Impact factor: 25.391

10.  High-level expression vectors to synthesize unfused proteins in Escherichia coli.

Authors:  A Seth; P Lapis; G F Vande Woude; T Papas
Journal:  Gene       Date:  1986       Impact factor: 3.688

View more
  9 in total

1.  Conservation of type-specific B-cell epitopes of glycoprotein G in clinical herpes simplex virus type 2 isolates.

Authors:  J A Liljeqvist; B Svennerholm; T Bergström
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

2.  Evaluation of three glycoprotein G2-based enzyme immunoassays for detection of antibodies to herpes simplex virus type 2 in human sera.

Authors:  A M Eis-Hübinger; M Däumer; B Matz; K E Schneweis
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

3.  Locations of herpes simplex virus type 2 glycoprotein B epitopes recognized by human serum immunoglobulin G antibodies.

Authors:  D E Goade; R Bell; T Yamada; G J Mertz; S Jenison
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

Review 4.  Laboratory techniques in the diagnosis of herpes simplex infection.

Authors:  R L Ashley
Journal:  Genitourin Med       Date:  1993-06

5.  Production of a fragment of glycoprotein G of herpes simplex virus type 2 and evaluation of its diagnostic potential.

Authors:  Tao Liu; Ji Feng Liu; Hua Yu; Guo Jing Si; Jun Hu; Jun Li
Journal:  Singapore Med J       Date:  2015-06       Impact factor: 1.858

6.  Peptide sequences of glycoprotein G-2 discriminate between herpes simplex virus type 2 (HSV-2) and HSV-1 antibodies.

Authors:  M Levi; U Rudén; B Wahren
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

7.  Comparison of two enzyme-linked immunosorbent assays and one rapid immunoblot assay for detection of herpes simplex virus type 2-specific antibodies in serum.

Authors:  J Groen; G Van Dijk; H G Niesters; W I Van Der Meijden; A D Osterhaus
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

Review 8.  Genital herpes: review of the epidemic and potential use of type-specific serology.

Authors:  R L Ashley; A Wald
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

9.  Comparative performance of a novel herpes simplex virus type 2-specific enzyme-linked immunosorbent assay using a targeted chain oligopeptide, peptide 55.

Authors:  A M Al-Sulaiman; P J Vallely; P E Klapper
Journal:  Clin Vaccine Immunol       Date:  2009-04-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.